|Day Low/High||137.96 / 139.77|
|52 Wk Low/High||118.62 / 148.99|
Deals already are popping up, and we'll soon have earnings reports from the industry giants.
We toured the company helping design cool workspaces for Fortune 500 companies like Facebook and Microsoft.
Shares of Johnson & Johnson are poised for a rally as the stock is currently trading about 8% off its 52-week high.
Johnson & Johnson could repatriate offshore profits in 2017 if a potential tax holiday is passed.
Animal health and oncology deal activity is heating up in 2017.
After a period of consolidation, several personal care products companies look like they are about to rally.
Disney and Goldman are doing a lot of the heavy lifting.
A big damage award against J&J has been reduced by a judge, but the company is still facing thousands of additional claims.
There may be some diamonds-in-the-rough among pharmaceutical consolidators and hospital chains.
Here is a look at some stocks that are poised for excellent dividend returns in 2017.
Jim Cramer wonders whether someone at Johnson & Johnson is now willing to pay more for Actelion, or if there was more give from the other side.
This is what you need to know before the opening bell on Thursday.
The Fed seems to have aligned itself with the new emerging themes of financials and small-caps.
Jim Cramer comments on Johnson & Johnson's move to abandon merger talks with Actelion.
The markets moved lower from the "get go," though about the time Sixty Minutes was on last evening the S&P 500 futures were up 10 handles. (Futures closed down 2.5 handles) Perhaps this is the start of a well due correction. Apropos, here is the q...
It's simply a little consolidation after a huge run. But could it develop?
There's a striking lack of volatility, and that's a flashing red warning signal.
But who are these buyers? Where are the sellers?
Jim Cramer is watching Johnson & Johnson, which may buy a Swiss drugmaker. Cramer says it's important to see how the deal is structured.
This stock needs more aggressive buying before it is an outright long.
It may be time to embrace the contrary. First issue (!!): The Palm Beach Chronicles. My weekly (brief) technical review of the markets -- cooling off ahead? BTIG's Stockton is bullish and so, as I have expressed, are most others! Campbell ...
Technical support and statistical evidence suggest the stock will rebound.
"If you work for a living, why the hell do you kill yourself working?" -- Tuco the Ugly "The Good, the Bad and the Ugly" I did only a small amount of trading today (and added to short exposure), and there will be no "Takeaways" today (it's family ti...
Jim Cramer takes a moment to honor American veterans, and the companies who are working to support them.
But don't buy blindly. There are too many companies that can be retaliated against.
"Dougie, take what Mr. Market gives you." -- Grandma Koufax And I did, Grandma Koufax. A consecutive nine-day market drop was snapped as we regained most that was lost in that period. Today was a great day. (Boy, would I like to annualize the pe...
After the election passes we are going to talk about companies again -- and these have done well.